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ABSTRACT: 
Introduction – Nuclear factor (erythroid-derived 2)-like factor 2 (Nrf2) is a transcription 
factor that regulates expression of many detoxification enzymes. Nrf2-antioxidant 
responsive element (Nrf2-ARE) signalling pathway can be a target for cancer 
chemoprevention. Glycyrrhiza glabra, common name, ‘liquorice’, is used as a sweetening 
and flavouring agent, and traditionally, to treat various ailments, and implicated to 
chemoprevention. However, its chemopreventive property has not yet been scientifically 
substantiated. 
Objective – To assess the ability of liquorice root samples to induce Nrf2 activation 
correlating to their potential chemopreventive property. 
Methods – The ability of nine methanolic extracts of liquorice root samples, collected 
from various geographical origins, to induce Nrf2 activation was determined by the 
luciferase reporter assay using the ARE-reporter cell line, AREc32. The antioxidant 
properties were determined by the 2,2-diphenyl-1-picryhydrazyl (DPPH) and the ferric-
reducing antioxidant power (FRAP) assays. 
Results – All extracts exhibited free-radical-scavenging property (RC50 = 136.39-635.66 
g/mL). The reducing capacity of ferrous ion was 214.46-465.59 M Fe(II)/g. Nrf2 
activation indicated that all extracts induced expression of ARE-driven luciferase activity 
with a maximum induction of 2.3 fold relative to control. These activities varied for 
samples from one geographical location to another.  
Conclusions – The present findings add to the existing knowledge of cancer 
chemoprevention by plant-derived extracts or purified phytochemicals, particularly the 
potential use of liquorice for this purpose.  
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Introduction 
Nuclear factor (erythroid-derived 2)-like factor 2 (Nrf2) is a transcription factor that 
regulates expression of many detoxification or antioxidant enzymes. Nrf2-antioxidant 
responsive element (Nrf2-ARE) signalling pathway is considered as a potential target for 
cancer chemoprevention, because activation of this pathway leads to the expression of a 
battery of cytoprotective genes that may hold the key to suppressing, delaying or reversing 
the progression of cancers (Kwak and Kensler, 2010). Thus, assessment of the ability of any 
natural products to induce cellular protein based antioxidant defence systems through the 
activation of Nrf2 transcription factor as determined by the luciferase assay using the 
antioxidant response element (ARE) reporter cell line, AREc32, can reveal potential cancer 
chemopreventive property of those natural products. This strategy was adopted in the 
present work to assess cancer chemopreventive potential of liquorice (Glycyrrhiza glabra) 
samples collected from various geographical origins. 
Glycyrrhiza glabra L. (family: Fabaceae), commonly known as ‘liquorice’ and widely 
cultivated in several parts of the world, including Afghanistan, China, Dagestan, Iran, Italy, 
Pakistan, Syria, Turkey and Uzbekistan, is a commercially valuable medicinal herb that is well 
known for its nutritional and medicinal properties for centuries (Hiroki and Hiroshi, 2009; 
Montoro et al., 2011; Zadeh et al., 2013; Russo et al., 2014). Because of its sweet taste, 
liquorice is used as an important sweetening and flavouring agent in food, tobacco and 
confectionery products. Traditionally, it has been used for the treatment of various human 
ailments, e.g., cough, upper and lower respiratory complications, kidney stones, hepatitis C, 
skin disorder, cardiovascular diseases, diabetes, gastrointestinal ulcers and stomach ache 
(Marjan and Hossein, 2008). It is also an important ingredient in medicinal oils for epilepsy, 
paralysis, rheumatism and haemorrhagic diseases. The benefits of liquorice in the treatment 
of diarrhoea, fevers, fever with delirium and anuria have also been well established (Marjan 
and Hossein, 2008; Vispute and Khopade, 2011; Zadeh et al., 2013). Extracts have been 
found to be useful in treating auto-immune conditions, and possess therapeutic benefit in 
immunodeficiency conditions.  It is also used as a tonic, particularly, for the spleen and the 
stomach, and implicated to chemoprevention (Vispute and Khopade, 2011). However, its 
chemopreventive property has not yet been substantiated by any mechanistic scientific 
evidence.  
Previous studies suggested that liquorice root extracts possess various useful 
pharmacological properties, including, anti-inflammatory, antimicrobial, antioxidant, 
antitussive, antiviral, cardioprotective, hepatoprotective and immunomodulatory actions 
(Kalaiarasi et al., 2009; Asha et al., 2012; Rajandeep et al., 2013; Astafeva and Sukhenko, 
2014; Dirican and Turkez, 2014 ). To date, more than 400 compounds have been isolated 
from various Glycyrrhiza species, and ca. 300 of these compounds are flavonoids (Marjan 
and Hossein, 2008). Among the compounds found in the genus Glycyrrhiza L, glycyrrhizin 
(also known as glycyrrhizic acid), a sweet-tasting triterpene saponin is the main active 
compound accounting for up to 2% of the dry material weight depending on species and 
growing regions, with other flavonoids such as arylcoumarins, chalcones, flavanones, 
flavanonols, flavones, flavonols, isoflavones, isoflavans, isoflavenes and isoflavanones 
(Marianna et al., 1995; Zhang and Ye, 2009) also being present in the plant.   
Glycyrrhizin has been shown to possess several pharmacological properties including 
inhibition of viral replication on numerous RNA and DNA viruses, such as hepatitis A and C, 
herpes simplex, herpes zoster, HIV, varicella zoster and CMV (Hirabayashi et al., 1991; 
Lakshmi and Geetha, 2011; Li et al., 2014). It inhibits hepatic metabolism of aldosterone 
(Lakshmi and Geetha, 2011), and possesses mineralocorticoid and glucocorticoid activity 
(Zadeh et al., 2013). Several other secondary metabolites from G. glabra showed 
hydrocortisone-like anti-inflammatory activity (Li et al., 2014), which was probably owing to 
inhibition of phospholipase A2 generally associated with various inflammatory processes 
(Okimasu et al., 1983). Glycyrrhizin also inhibits several factors of inflammatory process, 
e.g., cyclooxygenase activity, prostaglandin formation and to some extent, platelet 
aggregation (Akamatsu et al., 1991). 
In our previous work, quantification of glycyrrhizin in the methanol extracts of nine 
samples of G. glabra from different geographical origins was carried out by the semi-
preparative reversed-phase HPLC-PDA method (Basar et al., 2014). Concentration levels of 
glycyrrhizin were between 0.177 to 0.688 % w/w of dry extract. We now report on the 
comparative antioxidant capacity of these extracts as assessed by the 2,2-diphenyl-1-
picryhydrazyl (DPPH) and the ferric reducing antioxidant power (FRAP) assays, and potential 
cancer chemopreventive property of the extracts through induction of cellular protein 
based antioxidant defence systems via the activation of the nuclear factor (erythroid-
derived 2)-like factor 2 (Nrf2) transcription factor as determined using the antioxidant 
response element (ARE) reporter cell line, AREc32 (Wang et al., 2006). 
 
Experimental 
Reagents and chemicals 
All chemicals were purchased from Sigma-Aldrich (Dorset, UK), unless otherwise stated.  
Solvents were purchased form Fischer Scientific (Loughborough, UK). All cell culture 
reagents were purchased from Biosera (Nauaille, France).  Luciferase reporter assay system 
was purchased from Promega (Southampton, UK). 
 
Plant materials 
Commercial or experimental samples of roots of Glycyrrhiza glabra L. were collected from 
different geographical origins, identified appropriately by  the taxonomists in the source 
countries and stored under dry and cool conditions (15oC) (Table 1). Further macroscopic 
and chromatographic (HPLC) identification of all samples was carried out by Prof S Sarker at 
the Medicinal Chemistry and Natural Products Lab in Liverpool John Moores University, UK. 
 
Extraction and preparation of plant samples 
Ground dried roots (15 g each) were Soxhlet-extracted, sequentially, with n-hexane and 
methanol (MeOH), 400 mL each (Basar et al., 2014). Ten cycles were allowed for each 
extraction, and the temperature of the heating mantle for all extractions was kept constant 
at 60oC. The extracts were filtered and evaporated to dryness in a rotary evaporator at a 
temperature not exceeding 45oC. 
 
DPPH radical scavenging capacity 
The capacity of samples to scavenge DPPH was assessed as previously reported (Takao et 
al., 1994) with suitable modifications (Kumarasamy et al., 2007; Chima et al., 2014). DPPH (4 
mg) was dissolved in MeOH (50 mL) to obtain a concentration of 80 g/mL. The MeOH 
extracts were reconstituted in MeOH to obtain the test concentration of 10 mg/mL. 
Dilutions were made to obtain concentrations of 1.0, 0.1, 0.01, 0.001, 0.0001 and 0.00001 
mg/mL. Diluted solutions (1.00 mL each) were mixed with DPPH (1.00 mL) and allowed to 
stand in a dark chamber for 30 min for any reaction to take place. The DPPH-scavenging 
effect was evaluated by spectrophotometric at 517 nm against a blank. The values are 
reported as mean ±SD of three determinations.  
The percentage scavenging effect was calculated as: 
Scavenging rate, RC50 = [(A1 − A2) / A0] × 100% 
Where A0 is the absorbance of the control (without sample) and A1 is the absorbance in the 
presence of the sample, A2 is the absorbance of sample without DPPH radical.  
The scavenging ability of the samples was expressed as RC50 value, which is the 
effective concentration at which 50% of DPPH radicals were scavenged. The RC50 values 
were calculated from the relationship curve of scavenging activities (%) versus 
concentrations of respective sample. The experiment was performed in triplicate, and the 
average absorption was noted for each concentration. The decrease in absorption induced 
by the test compounds was compared with the the positive controls, ascorbic acid (1 mg/mL 
in MeOH). The antioxidant activity was expressed as the antioxidant activity index (AAI), 
calculated as follows (Scherer and Godoy, 2009). 
AAI = [final concentration of DPPH (g/mL) / RC50 (g/mL)] x 100 
 
Ferric reducing antioxidant power assay (FRAP) 
The FRAP assay was carried out according to the procedure previously reported by Benzie 
and Strain (1996).  The FRAP reagent was prepared by mixing acetate buffer (25 mL, 300 
mmol/L, pH 3.6), 10 mmol/L TPTZ solution (2.5 mL) in 40 mmol/L HCl and 20 mmol/L FeCl3 
solution (2.5 mL) in proportions of 10:1:1 (v/v), respectively. The FRAP reagent was 
prepared fresh and warmed to 37C in a water bath prior to use. 200 L of the samples (1 
mg/mL) was added to the FRAP reagent (1.8 mL). The reaction mixture was incubated in a 
water bath for 30 min at 37C. Then, the absorbance of the samples was measured at 593 
nm. The difference between absorbance of sample and the absorbance of blank was 
calculated and used to calculate the FRAP value. FRAP value was expressed in terms of mol 
ferrous ion equivalent per gram of sample dry weight using ferrous sulphate standard curve 
(y = 1.5596x + 0.1502, R2 = 0.9891). All measurements were calculated from the value 
obtained from triplicate assays.  
 
Cell lines and cell culture 
The stable human mammary ARE-reporter cell line (AREc32) was utilized to investigate the 
ability of extracts to activate the Nrf2 transcription factor.  All cell-lines were cultured in 
Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% foetal bovine serum 
(FBS), penicillin-streptomycin antibiotics suspension and geneticin (G418; 0.8 mg/mL).  All 
cells were cultured at 37C in 95% air and 5% CO2. The cells were seeded into 96 well plates 
at density 1.2 x 104 cells/well in a working volume of 200 µL/well and allowed to grow for 24 
h before each experiment commenced. The ability of the extract to induce Nrf2 activity was 
determined by the luciferase reporter assay.  
 
Luciferase reporter assay 
AREc32 cells were treated with 100 g/mL of the different root extracts of G. glabra for 24 
h. Cells were then washed with phosphate buffered saline (PBS) and luciferase reporter lysis 
buffer (Promega, USA) was added to each well followed by a freeze-thaw cycle to achieve 
complete cell lysis.  The cell lysate was then aspirated and dispensed into opaque 96-well 
plates. Luciferase reporter substrate was then added to each well and immediately the 
enzymatic activity was measured using a plate reader (ClarioStar). Levels of luciferase 
activity expressed by AREc32 cells following treatment with extracts was compared to the 
basal level of luciferase activity in controls (no treatment) and presented as a fold increase 
(relative to controls).  Each experiment was repeated at least three times with five replicates 
in each repeat. 
 
Statistical analysis 
All experiments were carried out in triplicate. Data were expressed as means ± standard 
deviation (SEM). The graph was plotted using non-linear regression with the use of 
GraphPad Prism version 6.0 for Windows (GraphPad Software, San Diego, CA, USA).  
 
 
 
 
 
Results and discussion 
Antioxidant activities 
Two different experimental approaches were employed for the determination of 
antioxidant activities. The DPPH assay is based on the capacity of biological reagents to 
scavenge the DPPH radical and is widely used in natural antioxidant studies because of its 
simplicity and sensitivity, whilst the FRAP assay has been extensively used to evaluate total 
antioxidant potential of plant extracts, and it assesses the ability of any test samples to 
reduce the ferric tripyridyltriazine (Fe(III)-TPTZ) complex to ferrous tripyridyltriazine (Fe(II)-
TPTZ) at a low pH (Benzie and Strain, 1996). In this study, methanol extracts of nine different 
samples of the roots of G. glabra collected from different geographical regions (Table 1) 
(Basar et al., 2014) were tested to compare their antioxidant activity.  
In the DPPH assay (Chima et al., 2014), sample P25 (collected from Uzbekistan) had 
the highest capability to scavenge DPPH free-radical with a RC50 value of 136.39 µg/mL 
(Table 2). Samples collected from the same cultivation region (Afghanistan) displayed 
significant differences in the DPPH radical scavenging activity as shown by the samples P12 
(RC50 336.70 µg/mL) and P14 (IC50 = 712.46 µg/mL).  The Antioxidant Activity Index (AAI) of 
all extracts was below 0.5, suggesting low antioxidant activity (Scherer and Godoy, 2009). 
Although the DPPH radical-scavenging abilities of the extracts were significantly lower than 
those of ascorbic acid, it was evident that the extracts did show some proton-donating 
ability and could serve as free-radical inhibitors or scavengers, acting possibly as primary 
antioxidants.  
The ferric reducing antioxidant power (in the FRAP assay) of the extracts (1 mg/mL) 
was in the range of 214.46-465.59 μmol Fe (II)/g (Table 3). The standard curve was 
generated in the range of 100 to 1000 M of ferrous sulphate and the results were 
expressed as mol ferrous ion equivalent per gram of sample dry weight (y = 1.5596x + 
0.1502, r2 = 0.9891). All samples showed approximately lower ferric reducing capacity 
compared to the standard reference ascorbic acid (889.63 ± 2.2 mol Fe (II)/g) (Table 3). 
Sample P12  (Afghanistan) exhibited higher capacity in reducing ferric ion (Fe3+) to ferrous 
ion (Fe2+) than to scavenging free-radicals with FRAP value 465.59 ± 3.2 mol Fe (II)/g), 
whereas a commercial sample, P04  (Dagestan) had the lowest FRAP value 214.46 ± 1.1 
mol Fe (II)/g). In general, samples collected from Afghanistan (P12), Uzbekistan (P25) and 
Syria (P20) demonstrated significant radical-scavenging activity in the DPPH and the FRAP 
assays. Previous phytochemical studies reported the presence of phenolic compounds (e.g., 
flavonoids), which are likely to be responsible for the antioxidant activity of G. glabra (Li et 
al., 2000; Kinoshita et al., 2005; Li et al., 2005; Sara-Franceschelli et al., 2011; Fu et al., 2013; 
Dong et al., 2014). The chemical structure and substitution pattern of hydroxyl groups of 
flavonoids dictate their antioxidant activity (Bors et al., 1990). In addition, quantitative 
differences of phenolic compounds in the extracts derived from various sources of G. glabra 
(Montoro et al., 2011), secondary metabolite profiles are subject to considerable variability 
not only according to geographic area, but also in relation to stage of plant maturity, 
genotype, environmental conditions, harvesting, processing and also diversity between 
populations (Douglas et al., 2004; Duffy et al., 2009; Zhang et al., 2011; Yu et al., 2015). The 
changes in the composition of the plant material affect its therapeutic value as well as the 
pharmacological activity. 
 
Assessment of induction of activation of Nrf2activity, and the luciferase assay 
Nrf2 is a bZIP protein encoded by the nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) 
gene, which contains conserved JUN and FOS regions that form the activator protein-1 (AP-
1) transcription factor for rendering various cellular processes linked to cell differentiation, 
proliferation and apoptosis (Ameyar et al., 2003; Lee and Johnson, 2004). Extensive research 
into the process of carcinogenesis has revealed the Nrf2/ARE signalling pathway as a 
potential target for cancer chemoprevention (Copple et al., 2008; Petri et al., 2012; Kou et 
al., 2013; Yang et al., 2015). Activation of this pathway leads to the expression of a battery 
of cytoprotective genes that may hold the key to suppressing, delaying or reversing the 
progression of neoplastic diseases. Transcriptional activation of protective genes is 
mediated by a cis-acting element called the antioxidant responsive element (ARE), where 
the transcription factor Nrf2 (NF-E2-related factor 2) binds to. Activation of this pathway 
protects cells from oxidative stress-induced cell death. It is already known that many 
phytochemicals can act as Nrf2 inducers (Kou et al., 2013) and prominent examples are 
epigallocatechin gallate from green tea, resveratrol from grapes and sulforaphane produced 
by cruciferous vegetables. To complete the investigation into the antioxidant and 
chemopreventive potential of the extracts of G. glabra, the AREc32 cell line was utilized to 
identify extracts capable of activating the transcription factor Nrf2, which has been reported 
to initiate the expression of up to 200 genes, many of which are involved in cellular defense 
against oxidative or toxic insult including heme-oxygenase 1 (HO-1), NAD(P)H:quinone 
oxidoreductase 1 (NQO1) and glutathione S-transferases (GSTs) (Wang et al., 2006; Copple 
et al., 2008).  
Prior to carrying out the luciferase assay, cellular toxicity assays (MTT) were 
conducted on the AREc32 cells using the extracts at a concentration of 100 g/mL, and no 
toxicity was detected in any extract (results not shown). All the extracts induced Nrf2 
activity with P20 producing the highest induction of 2.3 fold, followed by P12 (1.8 fold 
induction) (Figure 1). The ability of these two extracts to induce Nrf2 activity was consistent 
with the result of the antioxidant capacity of P20 and P12 in the FRAP assay, in which they 
showed the highest antioxidant activity (Table 3); in fact, the FRAP and Nrf2 activities were 
found to correlate quite well. Results from the present study have shown that the 
chemopreventive potential of G. glabra is mediated by the activation of Nrf2-dependent 
antioxidant defense mechanisms, similar to a recent finding where the anti-inflammatory 
potential of another medicinal plant, Antrodia salmonea, was found to be mediated by the 
activation of Nrf2-dependent antioxidant defense mechanisms (Yang et al., 2015). The fact 
that Nrf2 activation has been shown previously to be induced by plant phenolic compounds, 
e.g., flavonoids and stibenes (Bhullar and Rupasinghe, 2015), and that G. glabra is known to 
biosynthesise various flavonoids, it is reasonable to assume that the ability of G. glabra root 
extracts to activate Nrf2 is owing to the presence of various flavonoids. 
Herbal medicines, various nutraceuticals, dietary supplements, and phytochemicals 
are well known as effective cancer chemopreventive agents, which may retard, block or 
reverse carcinogenesis (Fazio and Ricciardielo, 2014). As standard chemotherapeutic 
regimes against cancer often render severe side-effects and complications in the post 
therapeutic management of the disease, cancer chemoprevention may therefore be the 
way forward to fight against cancer (Ullah et al., 2014). The present findings certainly add to 
the existing knowledge of cancer chemoprevention by plant-derived extracts or purified 
phytochemicals, particularly the potential use of liquorice for this purpose.  
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Figure 1. Induction of luciferase activity in AREc32 cells by the methanol extract of G. glabra 
root samples from different geographical locations 
Table 1. Glycyrrhiza glabra roots collected from different geographical origins  
Geographical 
origins 
Supplier details Sample number 
Consenza, 
Calabria, Italy 
Experimental sample from young plant, 
provided by Romano Radice di Liquirizia 
(Liquorice exporters), Cosenza, Calabria, 
Italy (www.radicediliquirizia.com) 
P01 
received 
November 2009 
P03 
received July 2010 
Uzbekistan 
Experimental sample provided by Dr 
Habibjon Kushiev, Gulistan State University, 
Uzbekistan and Dr Akmal Karimov, IWMI 
Tashkent, Uzbekistan 
P05  
harvested July 
2010 
P25  
harvested 
September 2011 
Afghanistan 
Commercial sample (unpeeled cut pieces) 
provided by Alfarid Corp., Karachi, Pakistan 
(www.alfarid.org)   
P12 
received August 
2010 
Commercial sample (selected yellow tip 
medium width) provided by Alfarid Corp., 
Karachi, Pakistan (www.alfarid.org) 
P14 
received August 
2010 
Dagestan 
Commercial sample provided by Kamil Aliev, 
Mitrada, Mahachkala, Dagestan, Russia 
http://mitrada.en.ec21.com/ 
P04 
received July 2010 
Damascus 
area, Syria 
Commercial chopped root sample from 
Philippe Robert Bittar, Liquorice exporters, 
Damascus 
(www.bonetwork.com/bfliquorice)        
P20 
received 
September 2010 
Anatolia, 
Turkey 
Experimental sample from young plant 
grown in Selçuk University experimental 
garden, Konya, Turkey. Provided by Dr 
Yuksel Kan. 
P22 
harvested 
September 2010 
Table 2. Free-radical scavenging activities of the methanol extracts of G. glabra root 
samples and ascorbic acid determined by the DPPH assay 
 
Sample RC50 value 
g/mL ± SD 
Antioxidant Activity Index 
(AAI) 
 
Ascorbic acid 
 
14.70 ± 0.7 
 
5.442 
P01 635.66 ± 2.4 0.1259 
P03 481.88 ± 3.6 0.1660 
P05 566.08 ± 2.9 0.1413 
P25 136.39 ± 0.9 0.5866 
P12 336.70 ± 1.1 0.2376 
P14 712.46 ±3.1 0.1123 
P04 628.62 ± 6.3 0.1273 
P20 411.22 ± 3.4 0.1945 
P22 607.81 ± 3.2 0.1316 
 
 
Table 3. The Ferric-Reducing Antioxidant Power (FRAP) activity for methanol extracts of G. 
glabra root samples and ascorbic acid 
 
 
 
 
 
 
 
 
 
 
 
Sample 
(1 mg/mL) 
FRAP 
mol Fe (II)/g ± SD 
 
Ascorbic acid 
 
889.63 ± 2.2 
P01 221.08 ± 1.3 
P03 344.19 ± 2.5 
P04 214.46 ± 1.1 
P05 302.73 ± 1.0 
P12 465.59 ± 3.2 
P14 257.20 ± 4.3 
P20 431.61 ± 2.4 
P22 333.08 ± 1.3 
P25 398.05 ± 1.4 
